Moreover, the laws of both countries need to establish enabling provisions that fulfil the requirements of the TRIPS Agreement, in particular draft Article 3 Ibis. This notification should include information concerning the beneficiary licensee, the products covered by the license, the quantity(ies) for which the license has been granted, its duration and the name of the beneficiary country(ies). Thus, the drugs produced under a compulsory license in the exporting country may be exported to several countries, provided these are all mentioned in the notification. The Annex contains a number of procedural requirements for the use of the draft Article 31 bis system.